OncoZenge AB's total assets for Q2 2026 were kr11.73M, a decrease of -0.64% from the previous quarter. DE:8LY total liabilities were kr17.03M for the fiscal quarter, a 48.81% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.